Top

Published in:

01-06-2009 | Original Article

Surgical Strategy for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Based on Prognostic Factors

Authors: Kazuhiro Kondo, Kazuo Chijiiwa, Masahiro Kai, Kazuhiro Otani, Koki Nagaike, Jiro Ohuchida, Masahide Hiyoshi, Motoaki Nagano

Published in: Journal of Gastrointestinal Surgery | Issue 6/2009

Abstract

Rationale

Surgical strategy for patients with hepatocellular carcinoma and portal vein tumor thrombus (PVTT) remains to be established.

Methods

From 1990 to 2008, 48 hepatocellular carcinoma patients with PVTT detected by preoperative imaging underwent hepatic resection, and their clinical data were retrospectively analyzed. Possible prognostic factors for survival were analyzed with postoperative survival curves, and significant factors were determined by univariate and multivariate analysis. The frequency of postoperative severe complications was investigated for each prognostic factor.

Results

Significant prognostic factors included patient age <60 years, serum total bilirubin (T-Bil) >0.8 mg/dl, serum aspartate aminotransferase >30 IU/L, serum alkaline phosphatase (ALP) >300 IU/L, tumor size >4 cm, PVTT in the main trunk (Vp4), and a surgical margin <1 mm by univariate analysis, and independent prognostic factors were serum T-Bil, ALP, and Vp4. No patient with Vp4 survived for more than 400 days after surgery, and frequency of postoperative severe complications in these Vp4 patients was significantly higher than in other Vp1–3 patients.

Conclusion

Hepatic resection as a first-choice treatment should be carefully selected in patients with Vp4 unless emergent removal of the PVTT is required.

Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005;40:225–235. doi:10.1007/s00535-005-1566-3.PubMedCrossRef

Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 2006;12:7561–7567.PubMed

Minagawa M, Makuuchi M, Takayama T, Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001;233:379–384. doi:10.1097/00000658-200103000-00012.PubMedCrossRef

Fukuda S, Okuda K, Imamura M, Imamura I, Eriguchi N, Aoyagi S. Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery 2002;131:300–310. doi:10.1067/msy.2002.120668.PubMedCrossRef

Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984;95:586–592.PubMed

Takasaki T, Kobayashi S, Suzuki S, Muto H, Marada M, Yamana Y, Nagaoka T. Predetermining postoperative hepatic function for hepatectomies. Int Surg 1980;65:309–313.PubMed

Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–649. doi:10.1002/bjs.1800600817.PubMedCrossRef

Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 2nd English ed. Tokyo: Kanehara, 2003.

Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y. Functional hepatic volume measured by technetium-99 m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 2001;96:541–546. doi:10.1111/j.1572-0241.2001.03556.x.PubMedCrossRef

10.

Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J. Hepatic resection is justified for elderly patients with hepatocellular carcinoma. World J Surg 2008;32:2223–2229. doi:10.1007/s00268-008-9688-4.PubMedCrossRef

11.

Sorensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 1993;67:773–775.PubMed

12.

Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992;111:518–526.PubMed

13.

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–213. doi:10.1097/01.sla.0000133083.54934.ae.PubMedCrossRef

14.

Liang LJ, Hu WJ, Yin XY, Zhou Q, Peng BG, Li DM, Lu MD. Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy. World J Surg 2008;32:627–631. doi:10.1007/s00268-007-9364-0.PubMedCrossRef

15.

Zhou J, Tang ZY, Wu ZQ, Zhou XD, Ma ZC, Tan CJ, Shi YH, Yu Y, Qiu SJ, Fan J. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. Hepatogastroenterology 2006;53:275–280.PubMed

16.

Ikai I, Hatano E, Hasegawa S, Fujii H, Taura K, Uyama N, Shimahara Y. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 2006;202:431–438. doi:10.1016/j.jamcollsurg.2005.11.012.PubMedCrossRef

17.

Ershler WB. Why tumors grow more slowly in old people. J Natl Cancer Inst 1986;77:837–839.PubMed

18.

Nagano H, Miyamoto A, Wada H, Ota H, Marubashi S, Takeda Y, Dono K, Umeshita K, Sakon M, Monden M. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Cancer 2007;110:2493–2501. doi:10.1002/cncr.23033.PubMedCrossRef

19.

Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Ota H, Nakamura M, Wada H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Monden M. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Hepatogastroenterology 2007;54:172–179.PubMed

20.

Ikenaga N, Chijiiwa K, Otani K, Ohuchida J, Uchiyama S, Kondo K. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg 2009;13:492–497.PubMedCrossRef

21.

Kumada K, Ozawa K, Okamoto R, Takayasu T, Yamaguchi M, Yamamoto Y, Higashiyama H, Morikawa S, Sasaki H, Shimahara Y, Yamaoka Y, Takeuchi E. Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery 1990;108:821–827.PubMed

22.

Ishikawa T, Imai M, Kamimura H, Tsuchiya A, Togashi T, Watanabe K, Seki K, Ohta H, Yoshida T, Kamimura T. Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study. World J Gastroenterol 2007;13:5465–5470.PubMed

23.

Kamiyama T, Nakanishi K, Yokoo H, Tahara M, Nakagawa T, Kamachi H, Taguchi H, Shirato H, Matsushita M, Todo S. Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol 2007;12:363–368. doi:10.1007/s10147-007-0701-y.PubMedCrossRef

24.

Ochiai T, Takayama T, Inoue K, Yamamoto J, Shimada K, Kosuge T, Yamazaki S, Makuuchi M. Hepatic resection with and without surgical margins for hepatocellular carcinoma in patients with impaired liver function. Hepatogastroenterology 1999;46:1885–1889.PubMed

25.

Hashimoto T, Minagawa M, Aoki T, Hasegawa K, Sano K, Imamura H, Sugawara Y, Makuuchi M, Kokudo N. Caval invasion by liver tumor is limited. J Am Coll Surg 2008;207:383–392. doi:10.1016/j.jamcollsurg.2008.02.017.PubMedCrossRef

Title: Surgical Strategy for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Based on Prognostic Factors
Authors: Kazuhiro Kondo
Kazuo Chijiiwa
Masahiro Kai
Kazuhiro Otani
Koki Nagaike
Jiro Ohuchida
Masahide Hiyoshi
Motoaki Nagano
Publication date: 01-06-2009
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 6/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-009-0854-2

At a glance: The STEP trials

Springer Medicine

Surgical Strategy for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Based on Prognostic Factors

Abstract

Rationale

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Rationale

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2009

Human NOTES Cholecystectomy: Transgastric Hybrid Technique

Hepaticojejunostomy vs. End-to-end Biliary Reconstructions in the Treatment of Iatrogenic Bile Duct Injuries

A Single-Institution Experience with Eight CD117-Positive Primary Extragastrointestinal Stromal Tumors: Critical Appraisal and a Comparison with Their Gastrointestinal Counterparts

Liver Recurrence of a Subcutaneous Temporal Hemangiopericytoma: The Index Case

Laparoscopic Left Hepatectomy with Intraoperative Biliary Exploration for Hepatolithiasis

Minimally Invasive Surgical Treatment of Sigmoidal Esophagus in Achalasia